Portfolio Holdings Detail for ISIN IE00BG11HV38
Stock Name / Fund iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker EEWD(USD) LSE
ETF Ticker EEWG(GBP) LSE
ETF Ticker EEWDx(GBP) CXE
ETF Ticker EMND.DE(EUR) CXE
ETF Ticker EEWD.L(GBP) LSE
ETF Ticker EEWG.L(GBP) LSE

Holdings detail for TEVA

Stock Name	Teva Pharma Industries Ltd ADR
Ticker	TEVA(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US8816242098
LEI	549300BAFGM4RC74ZJ94

Show aggregate TEVA holdings

News associated with TEVA

Medincell Reports Positive Phase 3 Safety Data For Olanzapine LAI; No PDSS Observed: (RTTNews) - Medincell SA (MEDCL.PA) reported that new long-term safety data from the completed Phase 3 SOLARIS trial support the potential of Olanzapine LAI (TEV-749) as the first long-acting olanzapine treatment option for schizophrenia, with no post-injection delirium/sedation - 2025-09-22 03:59:28
HEFA, EFA, TEVA, MNDY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Currency Hedged MSCI EAFE ETF (Symbol: HEFA) where we have detected an approximate $98.6 million dollar outflow -- that's a 1.5% decrease we - 2025-09-19 11:50:18
Tuesday's ETF with Unusual Volume: EFG: The iShares MSCI EAFE Growth ETF is seeing unusually high volume in afternoon trading Tuesday, with over 10.5 million shares traded versus three month average volume of about 647,000. Shares of EFG were down about 0.5% on the day. Components of that ETF with the highest volume - 2025-09-16 13:25:58
Noteworthy ETF Inflows: IDEV, CYBR, TEVA, CCEP: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI International Developed Markets ETF (Symbol: IDEV) where we have detected an approximate $366.0 million dollar inflow -- that's a 1 - 2025-09-08 12:03:35
Notable ETF Inflow Detected - IXUS, AER, TEVA, FUTU: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $129.6 million dollar inflow -- that's a 0.3% in - 2025-08-25 13:46:54
Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters: Key PointsQuarterly-filed Form 13Fs give investors a way to track which stocks Wall Street's best money managers are buying and selling. - 2025-08-20 04:51:00
US Bancorp DE Has $166,000 Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): US Bancorp DE lifted its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 6.5% in the first quarter, HoldingsChannel reports. The firm owned 10,812 shares of the company’s stock after purchasing an additional 656 shares during the period. US Bancorp DE’s holdings in Teva Pharmaceutical Industries were worth $166,000 at the end […] - 2025-08-17 05:46:51
Deutsche Bank AG Increases Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Deutsche Bank AG grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 16.9% in the 1st quarter, HoldingsChannel reports. The firm owned 2,589,607 shares of the company’s stock after buying an additional 375,064 shares during the quarter. Deutsche Bank AG’s holdings in Teva Pharmaceutical Industries were worth $39,802,000 as of its […] - 2025-08-13 05:18:59
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.71 Consensus PT from Analysts: Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price […] - 2025-08-04 02:43:01
Wall Street Zen Upgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Buy: Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. TEVA has been the subject of a number of other reports. JPMorgan Chase & Co. upgraded Teva Pharmaceutical Industries from a “neutral” rating […] - 2025-07-28 04:02:50
Signaturefd LLC Trims Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Signaturefd LLC decreased its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 28.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,768 shares of the company’s stock after selling 2,739 shares during the period. Signaturefd LLC’s holdings in […] - 2025-07-22 07:20:51
Head to Head Comparison: Teva Pharmaceutical Industries (NYSE:TEVA) vs. Taysha Gene Therapies (NASDAQ:TSHA): Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Profitability This table compares Taysha Gene […] - 2025-07-22 02:45:38
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters: Key PointsForm 13Fs provide investors with an over-the-shoulder look at which stocks Wall Street's brightest money managers are buying and selling. - 2025-07-18 04:06:00
Bank of New York Mellon Corp Sells 11,648 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Bank of New York Mellon Corp lessened its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,609,696 shares of the company’s stock after selling 11,648 shares during […] - 2025-07-17 04:32:51
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Sold by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 5.7% during the first quarter, HoldingsChannel reports. The firm owned 1,921,762 shares of the company’s stock after selling 116,779 shares during the period. Envestnet Asset Management Inc.’s holdings in Teva Pharmaceutical Industries were worth $29,537,000 at the end […] - 2025-07-15 05:14:50
DekaBank Deutsche Girozentrale Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): DekaBank Deutsche Girozentrale decreased its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,127 shares of the company’s stock after selling 1,453 shares during the period. DekaBank Deutsche Girozentrale’s […] - 2025-07-14 05:34:47
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.13 Consensus Price Target from Analysts: Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) have earned a consensus rating of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […] - 2025-07-10 02:50:52
GAMMA Investing LLC Sells 3,068 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): GAMMA Investing LLC trimmed its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 41.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,390 shares of the company’s stock after selling 3,068 shares during the […] - 2025-07-09 04:24:51
Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA): Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) saw some unusual options trading activity on Monday. Stock investors purchased 59,369 put options on the stock. This is an increase of approximately 93% compared to the typical volume of 30,826 put options. Teva Pharmaceutical Industries Stock Down 1.0% TEVA stock opened at $16.84 on Tuesday. […] - 2025-07-08 02:20:24
Retirement Systems of Alabama Makes New Investment in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Retirement Systems of Alabama acquired a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 401,249 shares of the company’s stock, valued at approximately $6,167,000. Other large investors […] - 2025-06-25 05:08:59
IXUS, TEVA, TME, MNDY: ETF Inflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $593.1 million dollar inflow -- that's a 1.3% in - 2025-06-20 12:07:30
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.: QRG Capital Management Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 12.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,430 shares of the company’s stock after selling 18,708 shares during […] - 2025-06-20 05:38:53
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters: There's nothing more valuable on Wall Street than data, and investors rarely have to dig to find something that's pertinent to the U.S. economy, the stock market, or their specific portfolio holdings. - 2025-06-16 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of “Buy” by Brokerages: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been given a consensus rating of “Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average […] - 2025-06-12 05:30:57
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Large Increase in Short Interest: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 38,700,000 shares, an increase of 36.1% from the April 30th total of 28,430,000 shares. Based on an average trading volume of 12,300,000 […] - 2025-06-04 05:04:50
Monday's ETF with Unusual Volume: EFAA: The Invesco MSCI EAFE Income Advantage ETF is seeing unusually high volume in afternoon trading Monday, with over 217,000 shares traded versus three month average volume of about 30,000. Shares of EFAA were down about 0.1% on the day. Components of that ETF with the highest vo - 2025-06-02 14:56:10
B. Riley Wealth Advisors Inc. Buys New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA): B. Riley Wealth Advisors Inc. bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,689 shares of the company’s stock, valued at approximately $214,000. Other hedge funds and other institutional […] - 2025-06-02 05:40:56
Teva Pharmaceutical Industries (NYSE:TEVA) Now Covered by Truist Financial: Truist Financial assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $25.00 price target on the stock. TEVA has been the topic of several other reports. Barclays reduced their price target on Teva Pharmaceutical Industries from […] - 2025-05-29 03:14:53
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead: The amount of data investors digest daily on Wall Street can sometimes feel overwhelming. Over the last six weeks, investors have navigated their way through earnings season, a Federal Reserve Open Market Committee meeting, and President Donald Trump's regularly changing tariff a - 2025-05-28 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Recommendation of “Buy” from Analysts: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price […] - 2025-05-23 06:58:47

iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP TEVA holdings

Date	Number of TEVA Shares Held	Base Market Value of TEVA Shares	Local Market Value of TEVA Shares	Change in TEVA Base Value	Current Price per TEVA Share Held	Previous Price per TEVA Share Held
2026-01-14 (Wednesday)	12,002	USD 391,745	USD 391,745	USD -1,801	USD 32.64	USD 32.79
2026-01-12 (Monday)	12,002	USD 393,546	USD 393,546	USD 9,362	USD 32.79	USD 32.01
2026-01-09 (Friday)	12,002	USD 384,184	USD 384,184	USD -6,001	USD 32.01	USD 32.51
2026-01-08 (Thursday)	12,002	USD 390,185	USD 390,185	USD 1,320	USD 32.51	USD 32.4
2026-01-07 (Wednesday)	12,002	USD 388,865	USD 388,865	USD 17,403	USD 32.4	USD 30.95
2026-01-02 (Friday)	12,002	USD 371,462	USD 371,462	USD -3,120	USD 30.95	USD 31.21
2025-12-31 (Wednesday)	12,002	USD 374,582	USD 374,582	USD -4,201	USD 31.21	USD 31.56
2025-12-29 (Monday)	12,002	USD 378,783	USD 378,783	USD -3,961	USD 31.56	USD 31.89

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TEVA by Blackrock for IE00BG11HV38

Show aggregate share trades of TEVA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-19 SELL -44 30.560 29.890 29.957 USD -1,318 18.27 Loss of -514 on sale
2025-12-17 BUY 44 30.205 29.875 29.908 USD 1,316 18.16
2025-12-16 SELL -44 30.420 29.840 29.898 USD -1,316 18.11 Loss of -518 on sale
2025-12-15 SELL -48 30.440 29.700 29.774 USD -1,429 18.06 Loss of -562 on sale
2025-12-10 SELL -72 29.800 28.810 28.909 USD -2,081 17.96 Loss of -788 on sale
2025-12-08 BUY 24 28.740 28.000 28.074 USD 674 17.91
2025-12-02 SELL -110 27.070 26.530 26.584 USD -2,924 17.79 Loss of -968 on sale
2025-11-20 BUY 192 24.890 24.210 24.278 USD 4,661 17.50
2025-11-18 BUY 63 25.070 24.220 24.305 USD 1,531 17.44
2025-11-12 SELL -120 25.880 25.190 25.259 USD -3,031 17.29 Loss of -956 on sale
2025-11-10 BUY 72 24.500 23.980 24.032 USD 1,730 17.22
2025-11-06 BUY 168 24.880 23.870 23.971 USD 4,027 17.15
2025-10-27 SELL -120 19.610 19.680 19.673 USD -2,361 17.01 Loss of -319 on sale
2025-10-20 SELL -72 19.420 19.450 19.447 USD -1,400 16.96 Loss of -179 on sale
2025-10-15 BUY 432 19.780 20.020 19.996 USD 8,638 16.92
2025-10-13 BUY 96 20.020 20.370 20.335 USD 1,952 16.89
2025-10-02 BUY 22 20.050 20.100 20.095 USD 442 16.87
2025-10-01 BUY 315 20.060 20.460 20.420 USD 6,432 16.85
2025-09-26 BUY 66 18.340 18.700 18.664 USD 1,232 16.82
2025-09-24 SELL -144 19.270 19.450 19.432 USD -2,798 16.79 Loss of -380 on sale
2025-08-04 BUY 288 15.690 15.780 15.771 USD 4,542 16.79
2025-07-16 BUY 24 16.010 16.100 16.091 USD 386 16.82
2025-07-10 SELL -110 16.530 16.770 16.746 USD -1,842 16.83 Profit of 9 on sale
2025-07-02 BUY 48 17.050 17.140 17.131 USD 822 16.83
2025-06-02 SELL -96 17.260 17.280 17.278 USD -1,659 16.77 Loss of -48 on sale
2025-05-30 BUY 132 16.780 17.470 17.401 USD 2,297 16.77
2025-05-29 SELL -72 17.530 18.280 18.205 USD -1,311 16.77 Loss of -103 on sale
2025-05-28 SELL -24 18.150 18.150 18.150 USD -436 16.76 Loss of -33 on sale
2025-05-22 SELL -360 16.940 17.080 17.066 USD -6,144 16.75 Loss of -115 on sale
2025-05-16 BUY 44 16.940 17.220 17.192 USD 756 16.74
2025-05-14 BUY 72 16.890 17.500 17.439 USD 1,256 16.74
2025-05-13 BUY 408 17.480 17.890 17.849 USD 7,282 16.74
2025-05-12 SELL -24 17.960 18.070 18.059 USD -433 16.73 Loss of -32 on sale
2025-04-23 SELL -48 14.290 14.610 14.578 USD -700 16.82 Profit of 108 on sale
2025-04-22 SELL -240 14.000 14.070 14.063 USD -3,375 16.85 Profit of 668 on sale
2025-04-11 BUY 44 13.460 13.460 13.460 USD 592 17.07
2025-04-09 BUY 44 14.160 14.330 14.313 USD 630 17.14
2025-04-08 SELL -112 13.590 14.410 14.328 USD -1,605 17.17 Profit of 319 on sale
2025-04-07 SELL -160 13.940 14.550 14.489 USD -2,318 17.21 Profit of 435 on sale
2025-04-04 BUY 24 13.800 14.530 14.457 USD 347 17.24
2025-03-27 BUY 96 15.490 15.800 15.769 USD 1,514 17.34
2025-03-11 BUY 600 16.100 16.220 16.208 USD 9,725 17.51
2025-03-07 BUY 48 15.360 15.460 15.450 USD 742 17.57
2025-03-06 BUY 44 15.350 15.740 15.701 USD 691 17.60
2025-03-03 SELL -88 16.000 16.530 16.477 USD -1,450 17.67 Profit of 105 on sale
2025-02-28 SELL -25,144 16.460 16.460 16.460 USD -413,870 17.68 Profit of 30,733 on sale
2025-02-26 BUY 2,993 16.780 17.130 17.095 USD 51,165 17.71
2025-02-18 SELL -2,079 16.570 17.150 17.092 USD -35,534 17.79 Profit of 1,460 on sale
2025-02-13 BUY 284 16.630 16.740 16.729 USD 4,751 17.86
2024-12-09 BUY 152 17.600 17.760 17.744 USD 2,697 17.70
2024-12-04 SELL -380 17.800 18.250 18.205 USD -6,918 17.70 Loss of -192 on sale
2024-12-03 SELL -1,716 17.530 17.790 17.764 USD -30,483 17.70 Loss of -103 on sale
2024-11-19 SELL -73 16.810 16.860 16.855 USD -1,230 18.07 Profit of 89 on sale
2024-11-18 SELL -76 16.490 16.500 16.499 USD -1,254 18.12 Profit of 123 on sale
2024-11-12 BUY 228 17.110 17.500 17.461 USD 3,981 18.16
2024-11-01 SELL -608 18.450 18.730 18.702 USD -11,371 18.33 Loss of -224 on sale
2024-11-01 SELL -608 18.450 18.730 18.702 USD -11,371 18.33 Loss of -224 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-19	SELL	-44	30.560	29.890	29.957	USD -1,318	18.27 Loss of -514 on sale
2025-12-17	BUY	44	30.205	29.875	29.908	USD 1,316	18.16
2025-12-16	SELL	-44	30.420	29.840	29.898	USD -1,316	18.11 Loss of -518 on sale
2025-12-15	SELL	-48	30.440	29.700	29.774	USD -1,429	18.06 Loss of -562 on sale
2025-12-10	SELL	-72	29.800	28.810	28.909	USD -2,081	17.96 Loss of -788 on sale
2025-12-08	BUY	24	28.740	28.000	28.074	USD 674	17.91
2025-12-02	SELL	-110	27.070	26.530	26.584	USD -2,924	17.79 Loss of -968 on sale
2025-11-20	BUY	192	24.890	24.210	24.278	USD 4,661	17.50
2025-11-18	BUY	63	25.070	24.220	24.305	USD 1,531	17.44
2025-11-12	SELL	-120	25.880	25.190	25.259	USD -3,031	17.29 Loss of -956 on sale
2025-11-10	BUY	72	24.500	23.980	24.032	USD 1,730	17.22
2025-11-06	BUY	168	24.880	23.870	23.971	USD 4,027	17.15
2025-10-27	SELL	-120	19.610	19.680	19.673	USD -2,361	17.01 Loss of -319 on sale
2025-10-20	SELL	-72	19.420	19.450	19.447	USD -1,400	16.96 Loss of -179 on sale
2025-10-15	BUY	432	19.780	20.020	19.996	USD 8,638	16.92
2025-10-13	BUY	96	20.020	20.370	20.335	USD 1,952	16.89
2025-10-02	BUY	22	20.050	20.100	20.095	USD 442	16.87
2025-10-01	BUY	315	20.060	20.460	20.420	USD 6,432	16.85
2025-09-26	BUY	66	18.340	18.700	18.664	USD 1,232	16.82
2025-09-24	SELL	-144	19.270	19.450	19.432	USD -2,798	16.79 Loss of -380 on sale
2025-08-04	BUY	288	15.690	15.780	15.771	USD 4,542	16.79
2025-07-16	BUY	24	16.010	16.100	16.091	USD 386	16.82
2025-07-10	SELL	-110	16.530	16.770	16.746	USD -1,842	16.83 Profit of 9 on sale
2025-07-02	BUY	48	17.050	17.140	17.131	USD 822	16.83
2025-06-02	SELL	-96	17.260	17.280	17.278	USD -1,659	16.77 Loss of -48 on sale
2025-05-30	BUY	132	16.780	17.470	17.401	USD 2,297	16.77
2025-05-29	SELL	-72	17.530	18.280	18.205	USD -1,311	16.77 Loss of -103 on sale
2025-05-28	SELL	-24	18.150	18.150	18.150	USD -436	16.76 Loss of -33 on sale
2025-05-22	SELL	-360	16.940	17.080	17.066	USD -6,144	16.75 Loss of -115 on sale
2025-05-16	BUY	44	16.940	17.220	17.192	USD 756	16.74
2025-05-14	BUY	72	16.890	17.500	17.439	USD 1,256	16.74
2025-05-13	BUY	408	17.480	17.890	17.849	USD 7,282	16.74
2025-05-12	SELL	-24	17.960	18.070	18.059	USD -433	16.73 Loss of -32 on sale
2025-04-23	SELL	-48	14.290	14.610	14.578	USD -700	16.82 Profit of 108 on sale
2025-04-22	SELL	-240	14.000	14.070	14.063	USD -3,375	16.85 Profit of 668 on sale
2025-04-11	BUY	44	13.460	13.460	13.460	USD 592	17.07
2025-04-09	BUY	44	14.160	14.330	14.313	USD 630	17.14
2025-04-08	SELL	-112	13.590	14.410	14.328	USD -1,605	17.17 Profit of 319 on sale
2025-04-07	SELL	-160	13.940	14.550	14.489	USD -2,318	17.21 Profit of 435 on sale
2025-04-04	BUY	24	13.800	14.530	14.457	USD 347	17.24
2025-03-27	BUY	96	15.490	15.800	15.769	USD 1,514	17.34
2025-03-11	BUY	600	16.100	16.220	16.208	USD 9,725	17.51
2025-03-07	BUY	48	15.360	15.460	15.450	USD 742	17.57
2025-03-06	BUY	44	15.350	15.740	15.701	USD 691	17.60
2025-03-03	SELL	-88	16.000	16.530	16.477	USD -1,450	17.67 Profit of 105 on sale
2025-02-28	SELL	-25,144	16.460	16.460	16.460	USD -413,870	17.68 Profit of 30,733 on sale
2025-02-26	BUY	2,993	16.780	17.130	17.095	USD 51,165	17.71
2025-02-18	SELL	-2,079	16.570	17.150	17.092	USD -35,534	17.79 Profit of 1,460 on sale
2025-02-13	BUY	284	16.630	16.740	16.729	USD 4,751	17.86
2024-12-09	BUY	152	17.600	17.760	17.744	USD 2,697	17.70
2024-12-04	SELL	-380	17.800	18.250	18.205	USD -6,918	17.70 Loss of -192 on sale
2024-12-03	SELL	-1,716	17.530	17.790	17.764	USD -30,483	17.70 Loss of -103 on sale
2024-11-19	SELL	-73	16.810	16.860	16.855	USD -1,230	18.07 Profit of 89 on sale
2024-11-18	SELL	-76	16.490	16.500	16.499	USD -1,254	18.12 Profit of 123 on sale
2024-11-12	BUY	228	17.110	17.500	17.461	USD 3,981	18.16
2024-11-01	SELL	-608	18.450	18.730	18.702	USD -11,371	18.33 Loss of -224 on sale
2024-11-01	SELL	-608	18.450	18.730	18.702	USD -11,371	18.33 Loss of -224 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TEVA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	1,326,567	3,941	2,847,921	46.6%
2025-09-18	1,947,007	4,426	4,674,643	41.7%
2025-09-17	1,292,039	11,664	4,003,062	32.3%
2025-09-16	2,251,053	34,178	4,868,209	46.2%
2025-09-15	2,578,420	1,100	6,567,436	39.3%
2025-09-12	2,617,292	3,861	5,387,054	48.6%
2025-09-11	1,863,296	20,567	4,067,649	45.8%
2025-09-10	2,057,028	20,419	5,058,829	40.7%
2025-09-09	2,177,348	1,452	6,082,565	35.8%
2025-09-08	2,198,386	10,526	5,200,404	42.3%
2025-09-05	1,747,079	9,493	4,271,667	40.9%
2025-09-04	2,087,450	6,830	4,093,858	51.0%
2025-09-03	2,032,226	1,600	5,035,501	40.4%
2025-09-02	2,391,634	1,654	6,813,173	35.1%
2025-08-29	1,374,476	8,978	3,008,168	45.7%
2025-08-28	1,177,487	2,946	3,118,002	37.8%
2025-08-27	1,884,393	6,555	3,323,171	56.7%
2025-08-26	1,914,180	3,249	4,260,238	44.9%
2025-08-25	1,407,463	420	3,321,523	42.4%
2025-08-22	2,604,235	0	6,684,840	39.0%
2025-08-21	3,825,586	11,389	9,899,001	38.6%
2025-08-20	1,144,097	4,878	3,530,095	32.4%
2025-08-19	1,739,267	2,524	6,118,138	28.4%
2025-08-18	1,882,607	8,592	5,438,373	34.6%
2025-08-15	2,099,823	11,013	4,305,316	48.8%
2025-08-14	2,419,794	1,706	5,478,472	44.2%
2025-08-13	1,584,588	14,939	4,845,265	32.7%
2025-08-12	1,591,669	1,500	3,589,467	44.3%
2025-08-11	1,671,914	3,200	4,204,809	39.8%
2025-08-08	2,394,847	0	5,125,370	46.7%
2025-08-07	2,680,059	10,954	6,786,021	39.5%
2025-08-06	2,688,426	464,286	5,933,923	45.3%
2025-08-05	2,444,362	403	5,927,095	41.2%
2025-08-04	2,580,270	15,606	7,333,660	35.2%
2025-08-01	2,963,212	367,256	7,094,545	41.8%
2025-07-31	3,200,207	11,249	9,684,594	33.0%
2025-07-30	4,694,488	8,581	11,845,322	39.6%
2025-07-29	2,050,848	4,084	7,443,233	27.6%
2025-07-28	2,220,328	59	6,554,156	33.9%
2025-07-25	1,667,723	1,282	4,447,672	37.5%
2025-07-24	1,993,998	2,359	4,968,343	40.1%
2025-07-23	1,911,526	10,691	5,766,862	33.1%
2025-07-22	1,643,601	135	4,872,100	33.7%
2025-07-21	1,325,474	800	3,789,650	35.0%
2025-07-18	1,955,501	5	5,942,642	32.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	EEWD(USD) LSE
ETF Ticker	EEWG(GBP) LSE
ETF Ticker	EEWDx(GBP) CXE
ETF Ticker	EMND.DE(EUR) CXE
ETF Ticker	EEWD.L(GBP) LSE
ETF Ticker	EEWG.L(GBP) LSE